
CREWT Medical Systems
A medical device manufacturer that contributes to improving QOV (Quality of Vision) in the world.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
$2.8m | Late VC | ||
Total Funding | 000k |
Related Content
CREWT Medical Systems, originating as a spin-off from major optical manufacturer HOYA Corporation in April 2013, operates as a research and development-driven venture in the medical device sector. The company was established by Tetsuya Eguchi, who serves as the President and CEO. Eguchi's background includes extensive experience in planning, development, regulatory affairs, and sales of laser-applied medical devices at a leading Japanese precision instrument manufacturer from 1986 to 2008. The company's name, CREWT, is an acronym for "Creation," "Weave," and "Technologies," reflecting its mission to create new value by integrating existing technologies.
The firm focuses on developing, manufacturing, and selling medical devices to improve what it terms 'Quality of Vision' (QOV). Its business model is centered on B2B sales of these devices to clients such as eye clinics, with a recorded delivery to over 200 clinics in Japan. A key product is the 'imo' series, particularly the 'IMOvifa', a head-mounted automated perimeter for visual field testing, crucial for diagnosing conditions like glaucoma. This device is designed to be portable and does not require a darkroom, unlike conventional larger equipment. This allows for testing in various settings, reducing the physical space needed and increasing patient comfort.
The IMOvifa incorporates several distinct features. It utilizes a proprietary algorithm called AIZE (Ambient Interactive ZEST), which employs Bayesian estimation to shorten measurement times compared to standard automated perimetry (SAP) while maintaining test performance. For instance, a test that takes over seven minutes with conventional methods can be completed in under six minutes with AIZE. The device also features a pupil tracking function that monitors both eyes with a near-infrared camera, automatically correcting the stimulus position to ensure accuracy, thereby reducing the burden on both patients and medical staff. Furthermore, it allows for tests to be conducted with both eyes open, which can enhance stability and comfort for the person being tested. The company is expanding its market reach, with plans for entry into European, Asian, and American markets.
Keywords: visual field testing, head-mounted perimeter, glaucoma diagnosis, medical device manufacturing, ophthalmic instruments, Quality of Vision (QOV), automated perimetry, eye care technology, AIZE algorithm, pupil tracking technology, portable medical devices, optometry instruments, vision assessment, retinal sensitivity, eye examination equipment, medical device spin-off, HOYA, Tetsuya Eguchi, ocular diagnostics, Japan healthcare